Vident Advisory, LLC

Position in ZTS — Zoetis Inc.

CIK 1744347 Alpharetta, GA

Position in ZTS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,435,477

-$3,795,370 QoQ

Shares Held

33,892

-35.7% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#457

of 1,408 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

Vident Advisory, LLC holds $34,283,611 across 24 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	317,141	$5,036,196
2	ALKS	Alkermes plc.	84,111	$4,407,415
3	UTHR	UNITED THERAPEUTICS Corp	6,535	$3,540,857
4	RDY	Dr Reddys Laboratories Ltd	187,312	$2,714,150
5	ZTS	Zoetis Inc. This page	33,892	$2,435,477
6	TAK	Takeda Pharmaceutical Co Ltd	143,921	$2,307,052
7	NBIX	Neurocrine Biosciences Inc	13,348	$2,249,670
8	HLN	Haleon plc	214,226	$1,998,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,435,477	33,892	-35.7%	Shares	Defined	2026-08-12
2026-03-31	$6,230,847	52,710	+4.2%	Shares	Sole	2026-05-15
2025-12-31	$6,361,836	50,563	-5.0%	Shares	Defined	2026-02-18
2025-09-30	$7,787,295	53,221	+13.6%	Shares	Defined	2025-11-14
2025-06-30	$7,308,283	46,863	-42.2%	Shares	Sole	2025-08-14
2025-03-31	$13,359,864	81,141	+135.3%	Shares	Defined	2025-05-15
2024-12-31	$5,618,151	34,482	+4.8%	Shares	Defined	2025-02-14
2024-09-30	$6,431,517	32,918	-13.4%	Shares	Sole	2024-11-14
2024-06-30	$6,590,106	38,014	-1.3%	Shares	Sole	2024-08-14
2024-03-31	$6,516,784	38,513	-4.4%	Shares	Sole	2024-05-14
2023-12-31	$7,948,088	40,270	+14.6%	Shares	Sole	2024-02-14
2023-09-30	$6,114,004	35,142	—	Shares	Defined	2024-02-21
No filing history on record for this holder in this stock.